Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SNGX
SNGX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SNGX News
Soligenix Initiates Vaccine Development for Bundibugyo Virus
Jun 08 2026
PRnewswire
Soligenix Advances Vaccine Development for Bundibugyo Virus
Jun 08 2026
Newsfilter
Biotech Stocks Pre-Market Trading Insights
Jun 03 2026
NASDAQ.COM
Q32 Bio Soars Over 85% on $55 Million Private Placement Announcement
May 28 2026
NASDAQ.COM
Soligenix's Vaccine Technology Addresses Ebola Outbreak
May 27 2026
NASDAQ.COM
Soligenix's Vaccine Platform Accelerates Development
May 27 2026
stocktwits
Soligenix Develops New Vaccine to Address Virus Outbreaks
May 26 2026
PRnewswire
Soligenix Develops New Vaccine to Address Virus Outbreaks
May 26 2026
Newsfilter
Soligenix Reports Q1 2026 Financial Results with $0.28 EPS
May 08 2026
seekingalpha
Soligenix Reports Q1 2026 Financial Results and Study Updates
May 08 2026
PRnewswire
SOLIGENIX RELEASES LATEST DEVELOPMENTS AND Q1 2026 FINANCIAL RESULTS
May 08 2026
moomoo
Latest Developments in the Biotech Sector
Apr 30 2026
NASDAQ.COM
Lucid, Soligenix, and Sportradar Shares Under Pressure Amid Setbacks
Apr 29 2026
stocktwits
Soligenix Faces Major Setback in Clinical Trial
Apr 28 2026
stocktwits
Soligenix Halts HyBryte Clinical Trial Due to Futility
Apr 28 2026
PRnewswire
Soligenix's FLASH2 Trial Halted Due to Futility, Future Uncertain
Apr 28 2026
Newsfilter
Show More News
